Live Breaking News & Updates on Associate Professor Erica Sloan

Stay updated with breaking news from Associate professor erica sloan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Big data used to identify existing drugs that could be repurposed for broader medical applications

Big data used to identify existing drugs that could be repurposed for broader medical applications
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South Australia , Carl Kirkpatrick , Pete Lambert , Erica Sloan , Jenni Ilom , Monash University , Monash Institute Of Pharmaceutical Sciences , Monash Centre Of Medicine , Monash Centre , Medicine Use , Safety Phd , George Tan , Monash Institute , Pharmaceutical Sciences , Professor Carl Kirkpatrick , Associate Professor Erica Sloan , Drug Discovery Biology , Drug Delivery Disposition ,

A breakthrough to make it beta: Blocking out stress to treat cancer

Monash Lens
Stress is bad, right? It feels bad, and is bad for you. The causes are different for everyone. But how exactly does stress – and nerves – relate to a chronic illness such as cancer?
Erica Sloan
Associate Professor, Drug Discovery Biology, Faculty of Pharmacy and Pharmaceutical Sciences
Monash University’s Associate Professor Erica Sloan, a scientist who specialises in cancer biology and neuro-immunology – how nerves talk to immune cells – began digging into this question 15 years ago, and is now able to say she’s getting much closer to the answers.
Those answers involve all these things – nerves, cells, the immune system, bodily organs, and also the ancient physiological phenomena known as the “fight or flight” response, or stress response. ....

South Australia , Peter Maccallum Cancer Centre , Monash University Associate Professor Erica Sloan , Associate Professor Erica Sloan , Professor Sloan , Health Report , Radio National , Associate Professor Sloan , Monash University , Cancer Research , Clinical Trial , Beta Blockers , Breast Cancer , Blood Cancer , தெற்கு ஆஸ்திரேலியா , பீட்டர் மக்காலம் புற்றுநோய் மையம் , இணை ப்ரொஃபெஸர் எரிகா ஸ்லோன் , ப்ரொஃபெஸர் ஸ்லோன் , ஆரோக்கியம் அறிக்கை , வானொலி தேசிய , மோனாஷ் பல்கலைக்கழகம் ,

Cardiac drug could reduce breast cancer spread and mortality

Share
A team of researchers from Monash University has discovered that a cardiac drug (carvedilol) could greatly reduce breast cancer progression, with those taking the drug at the time of diagnosis also much more likely to survive.
Carvedilol is a beta-blocker used to manage cardiovascular disorders including hypertension and chemotherapy induced heart disease.
In collaboration with a team from the Cancer Registry of Norway, the researchers investigated the effects of carvedilol in a large cohort of breast cancer patients (4,014) and found that if women happened to be taking carvedilol when they were diagnosed, they had a greater chance of survival than those not taking the drug. ....

South Australia , Bryan Gillis , Erica Sloan , Monash University , National Health Medical Research Council , Monash Institute Of Pharmaceutical Sciences , National Breast Cancer Foundation , National Breast Cancer Foundation Australia , Cancer Registry , European Journal , Monash Institute , Pharmaceutical Sciences , Associate Professor Erica Sloan , Professor Erica Sloan , National Health Medical Research , தெற்கு ஆஸ்திரேலியா , ரியான் கில்லிஸ் , எரிகா ஸ்லோன் , மோனாஷ் பல்கலைக்கழகம் , தேசிய ஆரோக்கியம் மருத்துவ ஆராய்ச்சி சபை , மோனாஷ் நிறுவனம் ஆஃப் மருந்து அறிவியல் , தேசிய மார்பக புற்றுநோய் அடித்தளம் , தேசிய மார்பக புற்றுநோய் அடித்தளம் ஆஸ்திரேலியா , புற்றுநோய் பதிவு , ஐரோப்பிய இதழ் , மோனாஷ் நிறுவனம் ,